文献速递结核与非结核分枝杆菌

儿童结核性脑膜炎的治疗与结局:欧洲儿科结核病网络试验组多中心研究

Treatment and Outcome in Children With Tuberculous Meningitis: A Multicenter Pediatric Tuberculosis Network European Trials Group Study.
PubMed 文献 · Clin Infect Dis · 2022-01-01

该多中心回顾性研究纳入9个欧洲国家27家儿科机构的118例结核性脑膜炎患儿,评估2014年WHO剂量建议修订前后的治疗与结局。49.1%患儿接受标准四药方案,病死率9.6%,仅47.1%完全康复;微生物学确诊、需神经外科干预和机械通气为不良结局的危险因素。

要点

  • 118例患儿中脑膜炎1期39例(33.1%)、2期68例(57.6%)、3期11例(9.3%)。
  • 104例有完整结局数据的患儿中病死率9.6%,完全康复率仅47.1%。
  • 微生物学确诊、需神经外科干预和机械通气为不良结局的危险因素。

核心结论

  • 该队列中抗结核药物使用存在相当大的异质性;尽管晚期患儿少且研究在高资源环境下进行,发病率与病死率仍较高。
  • 识别出的数个不良结局危险因素可能有助于未来对结核性脑膜炎患儿的预后判断。

研究设计与样本

  • 多中心、回顾性研究,通过欧洲儿科结核病研究网络纳入9个欧洲国家27家儿科医疗机构。
  • 纳入2014年世界卫生组织(WHO)剂量建议修订前后的结核性脑膜炎患儿共118例。

主要发现

  • 118例中脑膜炎1期39例(33.1%)、2期68例(57.6%)、3期11例(9.3%)。
  • 58例(49.1%)接受标准四药方案,其他常用药物包括链霉素、丙硫异烟胺和阿米卡星。
  • 48.3%(56/116)入住重症监护室,中位住院时间10天(四分位距4.5-21.0天)。
  • 104例有完整结局数据者中,9.6%(10/104)死亡,仅47.1%(49/104)完全康复。
  • 主要长期后遗症包括一个或多个肢体痉挛和发育迟缓,各占19.2%(20/104),癫痫发作性障碍占17.3%(18/104)。

关键数值与推荐

  • 多变量回归分析确定微生物学确诊结核性脑膜炎、需神经外科干预和机械通气为不良结局的危险因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Currently, data on treatment, outcome, and prognostic factors in children with tuberculous meningitis (TBM) in Europe are limited. To date, most existing data on TBM originate from adult studies, or studies conducted in low-resource settings. METHODS: We designed a multicenter, retrospective study involving 27 pediatric healthcare institutions in 9 European countries via an established pediatric TB research network, before and after the 2014 revision of World Health Organization (WHO) dosing recommendations. RESULTS: Of 118 children, 39 (33.1%) had TBM grade 1, 68 (57.6%) grade 2, and 11 (9.3%) grade 3. Fifty-eight (49.1%) children received a standard 4-drug treatment regimen; other commonly used drugs included streptomycin, prothionamide, and amikacin. Almost half of the patients (48.3%; 56/116) were admitted to intensive care unit, with a median stay of 10 (interquartile range [IQR] 4.5-21.0) days. Of 104 children with complete outcome data, 9.6% (10/104) died, and only 47.1% (49/104) recovered fully. Main long-term sequelae included spasticity of 1 or more limbs and developmental delay both in 19.2% (20/104), and seizure disorder in 17.3% (18/104). Multivariate regression analyses identified microbiological confirmation of TBM, the need for neurosurgical intervention, and mechanical ventilation as risk factors for unfavorable outcome. CONCLUSIONS: There was considerable heterogeneity in the use of TB drugs in this cohort. Despite few children presenting with advanced disease and the study being conducted in a high-resource setting, morbidity and mortality were high. Several risk factors for poor outcome were identified, which may aid prognostic predictions in children with TBM in the future.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Thee S, Basu Roy R, Blázquez-Gamero D, et al. Treatment and Outcome in Children With Tuberculous Meningitis: A Multicenter Pediatric Tuberculosis Network European Trials Group Study. Clin Infect Dis. 2022. PMID: 34849642. doi:10.1093/cid/ciab982

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。